Columbia Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.58M | Sell |
190,168
-4,092
| -2% | -$107K | 0.8% | 35 |
|
|
2026
Q1 | $5.45M | Buy |
194,260
+1,698
| +0.9% | +$45.2K | 1.04% | 27 |
|
|
2025
Q4 | $4.79M | Buy |
192,562
+10,449
| +6% | +$263K | 0.85% | 32 |
|
|
2025
Q3 | $4.64M | Sell |
182,113
-4,055
| -2% | -$100K | 0.87% | 32 |
|
|
2025
Q2 | $4.51M | Buy |
186,168
+15,957
| +9% | +$372K | 0.89% | 36 |
|
|
2025
Q1 | $4.31M | Buy |
170,211
+6,357
| +4% | +$166K | 0.84% | 34 |
|
|
2024
Q4 | $4.35M | Sell |
163,854
-28,637
| -15% | -$777K | 0.79% | 36 |
|
|
2024
Q3 | $5.57M | Sell |
192,491
-2,274
| -1% | -$66.3K | 0.97% | 32 |
|
|
2024
Q2 | $5.45M | Buy |
194,765
+46,297
| +31% | +$1.27M | 1.02% | 29 |
|
|
2024
Q1 | $4.27M | Buy |
148,468
+75
| +0.1% | +$2.08K | 0.87% | 36 |
|
|
2023
Q4 | $4.27M | Sell |
148,393
-15,726
| -10% | -$475K | 0.87% | 36 |
|
|
2023
Q3 | $5.44M | Buy |
164,119
+4,713
| +3% | +$167K | 1.2% | 23 |
|
|
2023
Q2 | $5.85M | Buy |
159,406
+6,297
| +4% | +$245K | 1.24% | 19 |
|
|
2023
Q1 | $6.25M | Buy |
153,109
+9,091
| +6% | +$393K | 1.41% | 17 |
|
|
2022
Q4 | $7.38M | Buy |
144,018
+5,507
| +4% | +$264K | 1.79% | 13 |
|
|
2022
Q3 | $6.06M | Buy |
138,511
+6,851
| +5% | +$333K | 1.59% | 13 |
|
|
2022
Q2 | $6.9M | Buy |
+131,660
| New | +$6.71M | 1.75% | 12 |
|
|
2021
Q4 | $7.43M | Buy |
125,832
+3,068
| +2% | +$152K | 1.51% | 16 |
|
|
2021
Q3 | $5.28M | Buy |
122,764
+9,753
| +9% | +$432K | 1.15% | 25 |
|
|
2021
Q2 | $4.42M | Sell |
113,011
-39,082
| -26% | -$1.52M | 0.98% | 34 |
|
|
2021
Q1 | $5.51M | Buy |
152,093
+14,164
| +10% | +$503K | 1% | 32 |
|
|
2020
Q4 | $5.08M | Sell |
137,929
-3,274
| -2% | -$120K | 1.02% | 33 |
|
|
2020
Q3 | $4.92M | Buy |
141,203
+1,876
| +1% | +$65.8K | 1.13% | 30 |
|
|
2020
Q2 | $4.32M | Buy |
139,327
+5,897
| +4% | +$200K | 1.03% | 33 |
|
|
2020
Q1 | $4.13M | Buy |
133,430
+22,437
| +20% | +$765K | 1.02% | 32 |
|
|
2019
Q4 | $41.3K | Buy |
110,993
+1,830
| +2% | +$65.2K | 0.99% | 33 |
|
|
2019
Q3 | $3.72M | Sell |
109,163
-711
| -0.6% | -$25.9K | 0.97% | 34 |
|
|
2019
Q2 | $4.52M | Sell |
109,874
-862
| -0.8% | -$34.2K | 1.19% | 26 |
|
|
2019
Q1 | $4.46M | Buy |
110,736
+464
| +0.4% | +$18.6K | 1.19% | 28 |
|
|
2018
Q4 | $4.57M | Sell |
110,272
-362
| -0.3% | -$15K | 1.39% | 24 |
|
|
2018
Q3 | $4.63M | Buy |
110,634
+2,707
| +3% | +$104K | 1.21% | 25 |
|
|
2018
Q2 | $3.71M | Buy |
107,927
+1,198
| +1% | +$40.9K | 1.08% | 31 |
|
|
2018
Q1 | $3.59M | Sell |
106,729
-722
| -0.7% | -$24.8K | 1.05% | 31 |
|
|
2017
Q4 | $3.69M | Buy |
107,451
+1,644
| +2% | +$56.1K | 1.06% | 31 |
|
|
2017
Q3 | $3.58M | Buy |
105,807
+4,227
| +4% | +$136K | 1.1% | 31 |
|
|
2017
Q2 | $3.24M | Sell |
101,580
-2,946
| -3% | -$92.9K | 1.04% | 33 |
|
|
2017
Q1 | $3.39M | Sell |
104,526
-1,152
| -1% | -$36.3K | 1.14% | 29 |
|
|
2016
Q4 | $3.26M | Buy |
105,678
+2,037
| +2% | +$62.2K | 1.1% | 30 |
|
|
2016
Q3 | $3.33M | Sell |
103,641
-1,664
| -2% | -$55.6K | 1.17% | 27 |
|
|
2016
Q2 | $3.52M | Buy |
105,305
+866
| +0.8% | +$27.6K | 1.25% | 23 |
|
|
2016
Q1 | $2.94M | Buy |
104,439
+4,722
| +5% | +$135K | 1.08% | 31 |
|
|
2015
Q4 | $3.05M | Sell |
99,717
-1,200
| -1% | -$37.8K | 1.23% | 21 |
|
|
2015
Q3 | $3.01M | Buy |
100,917
+429
| +0.4% | +$13.8K | 1.22% | 22 |
|
|
2015
Q2 | $3.2M | Buy |
100,488
+217
| +0.2% | +$7.07K | 1.22% | 21 |
|
|
2015
Q1 | $3.31M | Sell |
100,271
-687
| -0.7% | -$21.8K | 1.25% | 22 |
|
|
2014
Q4 | $2.98M | Buy |
100,958
+4,799
| +5% | +$138K | 1.15% | 23 |
|
|
2014
Q3 | $2.7M | Buy |
96,159
+1,090
| +1% | +$30.6K | 1.09% | 27 |
|
|
2014
Q2 | $2.68M | Buy |
95,069
+241
| +0.3% | +$6.87K | 1.09% | 25 |
|
|
2014
Q1 | $2.89M | Buy |
94,828
+2,374
| +3% | +$70.8K | 1.26% | 22 |
|
|
2013
Q4 | $2.69M | Buy |
+92,454
| New | +$2.69M | 1.19% | 25 |
|
Other funds holding PFE
AIM
SLAM
CWP
Columbia Asset Management's PFE Position: Q2 2026 in Review
Columbia Asset Management reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $107K and leaving 190,168 shares worth $4.58M. The position accounts for 0.8% of the portfolio, ranked #35.
Columbia Asset Management first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.43M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Columbia Asset Management held 190,168 shares of Pfizer worth $4.58M as of Q2 2026.
- Columbia Asset Management sold 4,092 Pfizer shares in Q2 2026, an estimated $107K.
- Pfizer made up 0.8% of Columbia Asset Management's portfolio in Q2 2026, its #35 holding.
- Columbia Asset Management first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
- Columbia Asset Management's Pfizer position peaked at $7.43M in Q4 2021.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Columbia Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.